BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29743815)

  • 1. Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer.
    Chan KKL; Siu MKY; Jiang YX; Wang JJ; Leung THY; Ngan HYS
    Cancer Cell Int; 2018; 18():65. PubMed ID: 29743815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Anti-Cancer Effects of ERB-041 and Genistein through Estrogen Receptor Suppression-Mediated PI3K/AKT Pathway Downregulation in Canine Mammary Gland Tumor Cells.
    Yoo MJ; Jang YJ; Park SY; Choi JW; Seol JW
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
    Cao F; Jin TY; Zhou YF
    Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
    Kostelac D; Rechkemmer G; Briviba K
    J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ERalpha- and ERbeta-mRNA and protein expresion.
    Staar S; Richter DU; Makovitzky J; Briese V; Bergemann C
    Anticancer Res; 2005; 25(3A):1713-8. PubMed ID: 16033089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
    Chen X; Anderson JJ
    Nutr Cancer; 2001; 41(1-2):165-71. PubMed ID: 12094620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid effects relevant to cancer.
    Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
    J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
    Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
    BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein inhibits the growth and regulates the migration and invasion abilities of melanoma cells via the FAK/paxillin and MAPK pathways.
    Cui S; Wang J; Wu Q; Qian J; Yang C; Bo P
    Oncotarget; 2017 Mar; 8(13):21674-21691. PubMed ID: 28423510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition.
    Banerjee A; Cai S; Xie G; Li N; Bai X; Lavudi K; Wang K; Zhang X; Zhang J; Patnaik S; Backes FJ; Bennett C; Wang QE
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin, but Not Genistein, Exerts Osteogenic and Anti-apoptotic Effects in Osteoblastic Cells by Selective Activation of Non-genomic ERα Signaling.
    Ho MX; Poon CC; Wong KC; Qiu ZC; Wong MS
    Front Pharmacol; 2018; 9():474. PubMed ID: 29867480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
    Kim EJ; Shin HK; Park JH
    J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein.
    Sotoca AM; Gelpke MD; Boeren S; Ström A; Gustafsson JÅ; Murk AJ; Rietjens IM; Vervoort J
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002170. PubMed ID: 20884965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative activity of daidzein and genistein may be related to ERα/c-erbB-2 expression in human breast cancer cells.
    Choi EJ; Kim GH
    Mol Med Rep; 2013 Mar; 7(3):781-4. PubMed ID: 23337939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
    Froyen EB; Steinberg FM
    J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein inhibits migration and invasion of cervical cancer HeLa cells by regulating FAK-paxillin and MAPK signaling pathways.
    Chen C; Wang Y; Chen S; Ruan X; Liao H; Zhang Y; Sun J; Gao J; Deng G
    Taiwan J Obstet Gynecol; 2020 May; 59(3):403-408. PubMed ID: 32416888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathways.
    Malloy KM; Wang J; Clark LH; Fang Z; Sun W; Yin Y; Kong W; Zhou C; Bae-Jump VL
    Am J Transl Res; 2018; 10(3):784-795. PubMed ID: 29636868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of microRNA associated with ovarian cancer cells by genistein.
    Parker LP; Taylor DD; Kesterson J; Metzinger DS; Gercel-Taylor C
    Eur J Gynaecol Oncol; 2009; 30(6):616-21. PubMed ID: 20099489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.